Y. Zuo et al. / Tetrahedron xxx (xxxx) xxx
5
134.3, 131.7, 128.8, 124.4, 120.5, 119.9, 119.1, 116.6, 114.9, 40.4, 34.3,
d 180.5, 142.8, 141.4, 135.1, 130.3, 130.0, 129.7, 129.6, 128.3, 128.1,
31.2,
28.3.
HRMS
(ESI)
calculated
for
C
21H26NO3S
127.1, 119.7, 119.3, 24.4, 21.5, 20.3. HRMS (ESI) calculated for
C
[M ꢀ H]e:372.1633; Found: 372.1637.
18H18NO2S [M ꢀ H]e:312.1058; Found: 312.1063.
4.2.12. N-(bis(2-hydroxy-5-methylphenyl)-4-sulfanylidene)
4.2.19. N-((E)-(5-chloro-2-hydroxyphenyl)((E)-4-methylstyryl)-l4-
acetamide (3l)
sulfanylidene)acetamide (5c)
White solid, yield: 76%. 1H NMR (400 MHz, CDCl3)
d
11.45 (s, 2H),
7.29e7.27 (m, 2H), 7.03 (d, J ¼ 8.5 Hz, 2H), 6.92 (s, 2H), 2.23 (s, 6H),
2.15 (s, 3H); 13C NMR (101 MHz, CDCl3)
181.5, 157.3, 135.8, 130.7,
White solid, yield: 72%, E/Z ¼ 12.5:1.1H NMR (400 MHz, CDCl3)
7.45 (d, J ¼ 15.4 Hz, 1H), 7.35 (t, J ¼ 5.6 Hz, 3H), 7.32 (dd, J ¼ 8.8,
d
d
2.5 Hz, 1H), 7.19 (d, J ¼ 8.0 Hz, 2H), 6.91 (d, J ¼ 8.8 Hz, 1H), 6.70 (d,
J ¼ 15.3 Hz, 1H), 2.37 (d, J ¼ 6.4 Hz, 3H), 2.19 (s, 3H); 13C NMR
128.7, 120.4, 115.1, 23.8, 20.4. HRMS (ESI) calculated for C16H16NO3S
[M ꢀ H]e:302.0851; Found: 302.0858.
(101 MHz, CDCl3)
d 181.1, 158.3, 143.5, 141.7, 134.0, 130.1, 129.8,
128.2, 127.4, 124.9, 121.2, 118.7, 117.0, 24.4, 21.5. HRMS (ESI) calcu-
lated for C17H15ClNO2S [M ꢀ H]e:332.0512; Found: 332.0516.
4.2.13. N-(bis(5-bromo-2-hydroxyphenyl)-4-sulfanylidene)
acetamide (3m)
White solid, yield: 62%. 1H NMR (400 MHz, CDCl3)
d 11.49 (s, 2H),
4.2.20. N-((E)-(5-bromo-2-hydroxyphenyl)((E)-4-methylstyryl)-
7.50 (dd, J ¼ 8.8, 2.3 Hz, 2H), 7.38 (d, J ¼ 2.3 Hz, 2H), 6.91 (d,
J ¼ 8.8 Hz, 2H), 2.24 (s, 3H); 13C NMR (101 MHz, CDCl3)
d 181.8,
l
4-sulfanylidene)acetamide (5d)
White solid, yield: 78%, E/Z ¼ 20:1.1H NMR (500 MHz, CDCl3)
7.46 (d, J ¼ 2.4 Hz, 1H), 7.45e7.37 (m, 2H), 7.33 (d, J ¼ 8.1 Hz, 2H),
158.1, 137.8, 130.4, 122.0, 117.0, 112.4, 24.0. HRMS (ESI) calculated for
C
14H10Br2NO3S [M ꢀ H]e:429.8748; Found: 429.8753.
d
7.16 (d, J ¼ 8.0 Hz, 2H), 6.81 (d, J ¼ 8.8 Hz, 1H), 6.67 (d, J ¼ 15.3 Hz,
1H), 2.35 (s, 3H), 2.17 (s, 3H); 13C NMR (126 MHz, CDCl3)
d 181.1,
4.2.14. (Z)-N-((2-hydroxy-5-methylphenyl)(2-hydroxyphenyl)-l4-
158.5, 143.3, 141.6, 136.7, 130.1, 130.0, 129.7, 128.2, 121.4, 118.7, 117.9,
111.5, 24.4, 21.5. HRMS (ESI) calculated for C17H15BrNO2S [M ꢀ H]e:
376.0007; Found: 376.0011.
sulfanylidene)acetamide (3n)
White solid, yield: 76%. 1H NMR (400 MHz, CDCl3)
d 11.51 (s, 2H),
7.44e7.38 (m, 1H), 7.23 (dd, J ¼ 8.4, 1.7 Hz, 1H), 7.16 (dd, J ¼ 8.1,
1.5 Hz, 1H), 7.06 (dd, J ¼ 8.3, 1.0 Hz, 1H), 6.97 (d, J ¼ 8.5 Hz, 2H),
6.92e6.86 (m, 1H), 2.21 (s, 3H), 2.16 (s, 3H); 13C NMR (101 MHz,
4.2.21. Methyl 3-((E)-N-acetyl-S-((E)-4-methylstyryl)
sulfinimidoyl)-4-hydroxybenzoate (5e)
CDCl3)
d 181.5, 159.2, 157.3, 135.7, 134.7, 130.6, 128.9, 128.6, 120.9,
120.4, 120.2, 116.4, 114.6, 23.9, 20.4. HRMS (ESI) calculated for
White solid, yield: 92%, E/Z ¼ 20:1.1H NMR (400 MHz, CDCl3)
C
15H14NO3S [M ꢀ H]e:288.0694; Found: 288.0701.
d
8.07 (dd, J ¼ 8.3, 1.6 Hz, 2H), 7.45 (d, J ¼ 15.4 Hz, 1H), 7.36 (d,
J ¼ 8.1 Hz, 2H), 7.19 (d, J ¼ 8.0 Hz, 2H), 7.04 (dd, J ¼ 7.9, 1.2 Hz, 1H),
4.2.15. (Z)-N-((5-chloro-2-hydroxyphenyl)(2-hydroxyphenyl)-l4-
6.73 (d, J ¼ 15.3 Hz, 1H), 3.89 (s, 3H), 2.37 (s, 3H), 2.18 (s, 3H); 13C
sulfanylidene)acetamide (3o)
NMR (101 MHz, CDCl3) d 180.4,165.4,164.4,143.7,141.8,135.3,131.2,
White solid, yield: 70%. 1H NMR (400 MHz, CDCl3)
d
11.34 (s, 2H),
130.0, 129.8, 128.3, 122.2, 120.2, 119.4, 114.5, 52.2, 24.3, 21.5. HRMS
7.43e7.33 (m, 2H), 7.31e7.24 (m, 2H), 6.99 (d, J ¼ 8.2 Hz, 1H), 6.92 (t,
(ESI) calculated for
358.1109.
C
19H20NO4S [MþH]þ: 358.1113; Found:
J ¼ 7.6 Hz, 1H), 6.87 (d, J ¼ 8.5 Hz, 1H), 2.25 (s, 3H); 13C NMR
(101 MHz, CDCl3)
d 181.6, 159.1, 157.2, 134.8, 134.4, 128.6, 127.1,
125.4,121.0,120.8,120.0,118.1, 114.7, 24.2. HRMS (ESI) calculated for
C
4.2.22. N-((E)-((E)-4-chlorostyryl)(2-hydroxyphenyl)-4-
sulfanylidene)acetamide (5f)
14H11ClNO3S [M ꢀ H]e:308.0148; Found: 308.0153.
White solid, yield: 75%, E/Z ¼ 20:1.1H NMR (400 MHz, CDCl3)
4.2.16. (Z)-N-((5-bromo-2-hydroxyphenyl)(2-hydroxyphenyl)-l4-
d
9.02 (s, 1H), 7.45 (d, J ¼ 7.7 Hz, 1H), 7.40e7.29 (m, 7H), 7.00 (d,
sulfanylidene)acetamide (3p)
J ¼ 8.2 Hz, 1H), 6.93 (t, J ¼ 7.5 Hz, 1H), 6.84 (d, J ¼ 15.4 Hz, 1H), 2.19
White solid, yield: 62%. 1H NMR (400 MHz, CDCl3)
d 11.55 (s, 2H),
(s, 3H); 13C NMR (101 MHz, CDCl3)
d
180.3, 159.4, 141.3, 136.9, 134.5,
7.45 (dd, J ¼ 11.3, 4.5 Hz, 2H), 7.30 (d, J ¼ 2.2 Hz, 1H), 7.25 (d,
131.4, 131.2, 129.34, 129.27, 129.1, 128.6, 128.4, 120.8, 120.5, 119.7,
24.3; HRMS (ESI) calculated for C16H13ClNO2S [M ꢀ H]e:318.0356;
Found: 318.0369.
J ¼ 7.7 Hz, 1H), 7.05 (d, J ¼ 8.3 Hz, 1H), 6.93 (t, J ¼ 7.6 Hz, 1H), 6.89 (d,
J ¼ 8.8 Hz, 1H), 2.20 (s, 3H); 13C NMR (101 MHz, CDCl3)
d 182.0,
159.4,158.1, 137.5, 135.0, 130.4, 128.9, 121.9, 121.0, 120.5, 118.2, 114.5,
112.2, 24.0. HRMS (ESI) calculated for
C14H11BrNO3S
[M ꢀ H]e:351.9643; Found: 351.9648.
4.2.23. N-((E)-((E)-4-bromostyryl)(2-hydroxyphenyl)-4-
sulfanylidene)acetamide (5g)
White solid, yield: 80%, E/Z ¼ 12.5:1.1H NMR (400 MHz, CDCl3)
4.2.17. N-((E)-(2-hydroxyphenyl)((E)-4-methylstyryl)-4-
d
7.52e7.47 (m, 2H), 7.44e7.35 (m, 2H), 7.33e7.27 (m, 3H), 7.01 (dd,
sulfanylidene)acetamide (5a)
White solid, yield: 85%, E/Z > 20:1.1H NMR (400 MHz, CDCl3)
7.47e7.32 (m, 5H), 7.18 (d, J ¼ 8.0 Hz, 2H), 7.04 (dd, J ¼ 8.4, 1.0 Hz,
J ¼ 8.3, 1.0 Hz, 1H), 6.95 (td, J ¼ 8.0, 1.2 Hz, 1H), 6.78 (d, J ¼ 15.3 Hz,
1H), 2.18 (s, 3H); 13C NMR (101 MHz, CDCl3)
d
181.0, 160.0, 140.9,
d
134.4, 132.2, 131.9, 129.5, 128.6, 125.2, 121.7, 120.3, 120.1, 114.5, 24.4;
HRMS (ESI) calculated for C16H13BrNO2S [M ꢀ H]e: 361.9850;
Found: 361.9854.
1H), 6.97e6.91 (m, 1H), 6.76 (d, J ¼ 15.3 Hz, 1H), 2.37 (s, 3H), 2.17 (s,
3H); 13C NMR (101 MHz, CDCl3)
d 180.7, 160.2, 142.8, 141.5, 134.3,
130.2, 129.7, 128.9, 128.1, 120.3, 120.2, 119.6, 114.9, 24.4, 21.5. HRMS
(ESI) calculated for
298.0909.
C
17H16NO2S [M ꢀ H]e:298.0902; Found:
4.2.24. N-((E)-((E)-4-(tert-butyl)styryl)(2-hydroxyphenyl)-4-
sulfanylidene)acetamide (5h)
4.2.18. N-((E)-(2-hydroxy-5-methylphenyl)((E)-4-methylstyryl)-
White solid, yield: 82%, E/Z ¼ 11:1.1H NMR (500 MHz, CDCl3)
l
4-sulfanylidene)acetamide (5b)
d
7.41e7.33 (m, 7H), 6.97 (d, J ¼ 7.9 Hz, 1H), 6.90 (t, J ¼ 7.6 Hz, 1H),
White solid, yield: 87%, E/Z ¼ 16:1.1H NMR (400 MHz, CDCl3)
9.09 (s, 1H), 7.38 (d, J ¼ 15.2 Hz, 1H), 7.32 (d, J ¼ 8.1 Hz, 2H), 7.17
6.74 (d, J ¼ 15.3 Hz, 1H), 2.17 (s, 3H), 1.28 (s, 9H). 13C NMR (126 MHz,
d
CDCl3)
d 180.8, 159.7, 154.4, 142.4, 134.1, 130.2, 128.4, 127.9, 125.9,
(dd, J ¼ 13.9, 8.2 Hz, 4H), 6.92 (d, J ¼ 8.1 Hz, 1H), 6.78 (d, J ¼ 15.3 Hz,
120.2, 119.81, 119.75, 115.5, 34.9, 31.1, 24.4; HRMS (ESI) calculated
1H), 2.34 (s, 3H), 2.27 (s, 3H), 2.17 (s, 3H); 13C NMR (101 MHz, CDCl3)
for C20H22NO2S [M ꢀ H]e: 340.1371; Found: 340.1377.
Please cite this article as: Y. Zuo et al., An internal oxidant-directing strategy enabling transition metal-free CeS bond ligation, Tetrahedron,